SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 31, 2003
MEDSOURCE TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 000-49702 52-2094496
-------- --------- ----------
(State or Other Jurisdiction (Commission File No.) (IRS Employer
of Incorporation) Identification No.)
110 Cheshire Lane, Suite 100, Minneapolis, MN 55305
- --------------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (952) 807-1234
Item 7. Financial Statements, Pro Forma Financial Financial Information.
---------------------------------------------------------------
(a) Financial Statements of Business Acquired:
Not applicable
(b) Pro Forma Financial Information:
Not applicable
(c) Exhibits.
99.1 MedSource Technologies, Inc. Press Release dated
July 31, 2003
Item 9. Regulation FD Disclosure.
------------------------
This information, furnished under "Item 9. Regulation FD Disclosure,"
is intended to be furnished under "Item 12. Results of Operations and Financial
Condition" in accordance with Securities and Exchange Commission Release No.
33-8216. The information in this Current Report Form 8-K, including the Exhibit
attached hereto, shall not be deemed "filed" for purposes of Section 18 of the
Securities Act of 1934, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, except as expressly set forth by
specific reference in such filing.
On July 31, 2003, MedSource Technologies, Inc. issued a press release
announcing its results of operations for its fiscal fourth quarter and year
ended June 30, 2003. A copy of the press release is attached as Exhibit 99.1 and
is incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: July 31, 2003
MEDSOURCE TECHNOLOGIES, INC.
By: /s/ William J. Kullback
-------------------------------------
William J. Kullback
Senior Vice President - Finance
and Chief Financial Officer
EXHIBIT INDEX
-------------
Exhibit No. Description
- ----------- -----------
99.1 MedSource Technologies, Inc. Press Release dated July 31, 2003